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Abstract
Alcohol consumption is associated with an increased 
risk of breast cancer, increasing linearly even with a 
moderate consumption and irrespectively of the type of 
alcoholic beverage. It shows no dependency from other 
risk factors like menopausal status, oral contraceptives, 
hormone replacement therapy, or genetic history of 
breast cancer. The precise mechanism for the effect 
of drinking alcohol in mammary cancer promotion is 
still far from being established. Studies by our labora-
tory suggest that acetaldehyde produced in situ  and 
accumulated in mammary tissue because of poor de-
toxicating mechanisms might play a role in mutational 
and promotional events. Additional studies indicated 
the production of reactive oxygen species accompanied 
of decreases in vitamin E and GSH contents and of 
glutathione transferase activity. The resulting oxida-
tive stress might also play a relevant role in several 
stages of the carcinogenic process. There are reported 
in literature studies showing that plasmatic levels of 
estrogens significantly increased after alcohol drinking 
and that the breast cancer risk is higher in receptor ER-
positive individuals. Estrogens are known that they may 
produce breast cancer by actions on ER and also as 
chemical carcinogens, as a consequence of their oxida-
tion leading to reactive metabolites. In this review we 
introduce our working hypothesis integrating the ac-
etaldehyde and the oxidative stress effects with those 
involving increased estrogen levels. We also analyze 
potential preventive actions that might be accessible. 
There remains the fact that alcohol drinking is just one 
of the avoidable causes of breast cancer and that, at 
present, the suggested acceptable dose for prevention 
of this risk is of one drink per day.
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Core tip: Excessive alcohol drinking of any type of al-
coholic beverage is known to linearly increase the risk 
of breast cancer. The precise mechanism involved to 
produce this effect is still far from being established. In 
this review we introduce our present working hypoth-
esis integrating the participation in cancer initiation and 
promotion of: in situ  accumulation of the acetaldehyde 
metabolite, the local promotion of oxidative stress and 
the effects of the increased levels of estrogen occurring 
during alcohol drinking. Some potential preventive al-
ternatives were also analyzed.
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EPIDEMIOLOGY OF ALCOHOL DRINKING 
INDUCED BREAST CANCER
Alcohol drinking is causally related to an increased risk 
of  cancer of  the upper aero-digestive tract, liver, col-
orectum, and female breast[1-4]. Of  particular concern is 
the case of  breast cancer promotion by chronic alcohol 
consumption. In effect, breast cancer is an extremely 
relevant cause of  disease and death in women and alco-
hol intake is one of  the few modifiable risk factors for 
breast cancer. The International Agency for Research 
on Cancer recently reported that by 2010 more than 100 
epidemiological studies have evaluated the association 
between the consumption of  alcoholic beverages and 
the risk of  breast cancer[4]. Further, combined analysis 
of  data from 53 studies around the world showed a clear 
dose-response relationship between alcohol consumption 
and increased risk of  breast cancer[2]. This study showed 
9% increase in risk per 10 g intake of  alcohol per day. In 
fact, other recently epidemiological studies in a total of  
1280296 middle-aged women in the United Kingdom re-
ported that even drinking women consuming an average 
in only 10 g of  alcohol (one drink) per day showed 12% 
increased risk of  breast cancer[1]. In addition, a detailed 
prospective study in 254870 women, made in eight Eu-
ropean countries, reported that 5% of  the female breast 
cancer was attributable to alcohol consumption[5]. 
Unfortunately, there is limited information regarding 
a possible mechanism for this effect and about positive 
modulatory effects of  dietary factors if  alcohol drinking 
is not avoided. That issue was of  particular interest in the 
studies made by our laboratory and by other workers[6-9]. 
In this review we are going to describe our working hy-
pothesis on the pathogenesis of  alcohol drinking induced 
mammary cancer and its potential prevention.
ACETALDEHYDE FORMATION, 
ACCUMULATION AND EFFECTS
Despite the relevance of  the problem, the mechanism for 
ethanol-increased risk of  breast cancer remains unknown.
Several lines of  evidence indicate that acetaldehyde, 
a product of  alcohol metabolism, might play a role in 
alcohol-related carcinogenic effects in different target tis-
sues[10,11]. Animal experiments have clearly shown that ac-
etaldehyde is an established mutagenic and carcinogenic 
chemical[12-14]. In addition, other factors such as oxidative 
stress, altered methyl transfer, abnormal metabolism of  
vitamin A and retinoic acid and perturbed levels of  hor-
mones might be of  particular relevance according to the 
target tissue involved[3,8].
Concerning the specific case of  mammary tissue, the 
knowledge of  the acetaldehyde concentrations was of  
particular interest to our laboratory. In general terms, the 
concentration of  acetaldehyde in any tissue, and also in 
the mammary, depends of  its ability to produce it in situ, 
plus the additional arriving to the organ via blood supply 
and in the capacity of  the given organ to degrade it[15].
The ability of  mammary tissue to produce acetalde-
hyde in situ was studied in our laboratory. The available 
information was scarce to null at that time. Two different 
pathways of  bioactivation of  ethanol to acetaldehyde 
were reported by our laboratory to be present in the rat 
mammary tissue. One is in the cytosolic fraction and 
the other is in microsomes[16,17]. Both were preliminary 
characterized and showed to be susceptible to inhibitory 
effects by chemicals present in food (this last subject will 
be analyzed ahead when discussing the preventive poten-
tial of  findings).
The enzyme involved in the cytosolic pathway was 
evidenced to be xanthine oxidoreductase (XOR) because 
of  its susceptibility to inhibitory effects of  allopurinol 
and by the ability of  the process to occur only when the 
presence of  NAD+ was accompanied by substrates of  
the XOR form of  the enzyme such as hypoxanthine, 
xanthine, caffeine, theobromine, theophylline or 1,7-di-
methylxanthine[16].
Moreover, it is also known that during acute alcohol 
intoxication, there is an increased purine degradation 
and hyperuricemia[18,19]. The enhanced supply of  purines 
resulting from this process could also provide an extra 
amount of  cofactors for the XOR-mediated pathway 
of  metabolism of  ethanol to acetaldehyde (and also free 
radicals) in the mammary tissue.
The presence of  XOR in mammary tissue is well 
known[20,21], and past studies from our laboratory evi-
denced their presence in high amounts in the rat mam-
mary tissue epithelial cells[22]. Interestingly, the activity of  
this cytosolic pathway significantly increased after repeti-
tive alcohol drinking through a Lieber and De Carli diet 
for 28 d[22].
The contribution of  enzymes present in cytosolic 
fraction of  mammary tissue, other than XOR, to the ac-
tivation of  ethanol to acetaldehyde, for example, alcohol 
dehydrogenase (ADH) may be more limited. On one 
hand, previous studies[23] showed that no ADH activity 
was found in homogenates of  rat mammary tissue. More 
recently, our laboratory reported traces of  ADH activ-
ity in the cytosolic fraction of  mammary tissue that was 
about 16 times smaller than in the liver[15]. By the other 
hand, Triano et al[24] reported that human mammary tis-
sue contains a class of  ADH having a limited potential to 
transform alcohol to acetaldehyde.
In addition to the mammary tissue cytosolic pathway 
of  ethanol oxidation to acetaldehyde described above, 
our laboratory reported the presence of  another one oc-
curring in the microsomal fraction of  that tissue[17].
In our earlier studies of  that pathway it was estab-
lished that the enzymatic transformation involved was 
oxygen and NADPH-dependent, but that the cyto-
chrome P450 was not involved because it was not inhib-
ited by CO:O2 (80:20 v/v) or by SFK525A[17].
Interestingly, this microsomal transformation of  alco-
hol to acetaldehyde was strongly inhibited by diphenyle-
neiodonium (DPI), sodium diethyldithiocarbamate, sodi-
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um azide, nordihydroguaiaretic acid but not by dapsone, 
aminotriazole or indomethacin. Those results suggested 
us the potential participation in this biotransformation of  
an oxidase or a peroxidase but not of  lactoperoxidase or 
cyclooxygenase[17]. We were unable to detect the forma-
tion of  either hydroxyl or 1-hydroxyethyl radicals in those 
studies. In the course of  following studies performed at 
the opportunity in rats exposed to a standard Lieber and 
De Carli diet for 28 d, we observed the induction not 
only of  XOR cytosolic activation pathways but also of  
the microsomal one[22].
That was of  particular significance, since we showed 
in the course of  additional recent work that the enhanc-
ing effect is not due to the participation of  CYP2E1 after 
chronic alcohol drinking as it is known for the liver mi-
crosomal fraction[25].
Further, acetone, another inducer of  microsomal CY-
P2E1-mediated alcohol metabolism in liver microsomes, 
failed to enhance ethanol bioactivation and CYP2E1 
enzymatic activity in the microsomal rat mammary tis-
sue[25]. To ensure that CYP2E1 enzymatic activity in the 
microsomal rat mammary tissue was not present or was 
very low, we also included in those studies determination 
of  chlorzoxazone hydroxylase activity. This activity was 
considered in literature as having a significant response to 
the presence of  CYP2E1 in a given tissue[25]. We were not 
able to detect CYP2E1-mediated metabolism of  chlor-
zoxazone in the mammary tissue microsomal fraction de-
spite the fact we employed a particularly sensitive proce-
dure developed in our laboratory, where the formation of  
6-hydroxychlorzoxazone metabolite could be determined 
by HPLC with coulometric detection[25]. That further ex-
cluded the participation of  CYP2E1 in this microsomal 
pathway of  alcohol metabolism in the mammary tissue 
and encouraged us to challenge the possibility that a per-
oxidase or a lipoxygenase was involved in that process 
instead. That hypothesis was originally coined because 
of  the potent inhibitory effect of  nordihydroguaiaretic 
acid. This polyphenol is a known inhibitor of  lipoxy-
genases[26,27]. We also envisaged the possibility that the 
potent inhibitory effect of  DPI could be suggesting the 
additional participation of  a NADPH oxidase enzyme 
as a supplier of  hydrogen peroxide. Under this view, the 
role of  NADPH oxidase would be the generation of  
the necessary co-substrate required by lipoxygenase to 
exert its activity against xenobiotics[8]. On behalf  of  this 
hypothesis is the fact that the specific inhibitory effect 
of  DPI on NADPH oxidase is well established[28]. That 
hypothesis visualizes the overall process of  microsomal 
ethanol oxidation to acetaldehyde in rat mammary tissue 
as a cooperative mechanism between NADPH oxidase 
and lipoxygenase (Figure 1). 
The concentration of  acetaldehyde in different tissues 
depends on the production and degradation of  acetalde-
hyde and on the amount of  it arriving to the given tissue 
via blood supply. In a detailed study from our laboratory, 
we attempted to evaluate how much acetaldehyde accu-
mulates in mammary tissue after single doses of  ethanol 
and also the levels of  it arriving via blood at different 
periods of  time. The studies were performed at three dif-
ferent dose levels (high, medium and low). Values were 
compared with the equivalent occurring in liver[15].
The levels of  acetaldehyde in mammary tissue were 
higher than in plasma and lower than in liver for at least 
15 h for the higher dose tested or six hours for the me-
dium dose or two hours for the case of  the lower one. 
The shape of  the curve concentration of  acetaldehyde in 
mammary tissue vs time after p.o. administration always 
mimicked that observed in liver. But, more important, the 
levels of  acetaldehyde in plasma were similar for the three 
ethanol doses given[15]. These results suggest that acetal-
dehyde present in the mammary tissue (and in the liver) 
reflects the balance between the ability of  these tissues 
to generate acetaldehyde and the one to metabolize and 
excretes it. The liver is able to get rid of  the acetaldehyde 
formed with the participation of  aldehyde dehydrogenase 
(ALDH) and glutathione transferase (GST)[19]. In the case 
of  mammary tissue the situation appears to be different. 
On one hand, ADH activity is about 16 times smaller 
than in the liver, but perhaps more important, ALDH 
activity present in three subcellular fractions tested in our 
study were in all of  them at least ten times smaller than 
in the liver[15]. 
The overall conclusion of  those results was that ac-
etaldehyde is able to accumulate during significantly rel-
evant periods of  time in mammary tissue mainly as result 
of  its ability to oxidize ethanol to acetaldehyde in situ and 
to a less important extent to the arrival of  it via blood 
and produced elsewhere (for example, in the liver)[15]. 
Which might be the expected consequences of  acet-
aldehyde accumulation in a given tissue for long lasting 
periods of  time?
It is important to point out that acetaldehyde is a 
reactive chemical that proved to be toxic, mutagenic and 
carcinogenic and able to interact with many cellular con-
stituents, including DNA, proteins (nuclear proteins), lip-
ids (including nuclear lipids), glutathione and others[19,29,30].
The reactions of  acetaldehyde with DNA are of  par-
ticular concern because they clearly suggest that it acts as 
a tumor initiator and mutagenic compound. Structures of  
the identified DNA adducts of  acetaldehyde were recent-
ly reviewed in literature[31-33]. Representative structures are 
shown in Figure 2.
DNA adducts may cause polymerase errors and in-
duce mutations in critical genes. Furthermore, they may 
lead to mutations that activate proto-oncogenes and inac-
tivate tumor suppressor genes in replicating cells[34,35]. 
Notwithstanding, there are known DNA repair en-
zymes that can modify DNA damage caused by acetal-
dehyde, removing its adducts from DNA. The relation 
between adducts formation and their repair would be rel-
evant to molecular epidemiology of  cancer, particularly 
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NADPH oxidase: NADPH + H+ + O2              NADP+ + H2O2
Lipoxygenase: H2O2 + CH3CH2OH             2 H2O + CH3CHO
Figure 1  Cooperative mechanism between NADPH oxidase and lipoxy-
genase in the oxidation of ethanol to acetaldehyde in microsomes.
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covalent interactions and carcinogenicity[39].
In addition, is important to take in mind that ethanol 
is a well known inducer of  CYP2E1-mediated metabo-
lisms[19] and that this enhancing effect was observed in 
the outer nuclear membrane of  the liver[40,41].
Far reaching consequences may also be expected from 
alterations in nuclear proteins resulting from an attack by 
acetaldehyde. In effect, it is known that nuclear proteins 
are critical for cell division, growth, differentiation and 
apoptosis[42-44]. A clear example of  relevant nuclear pro-
teins is the one of  those involved in the cell cycle clock. 
They include cyclins, cyclin-dependent kinases; protein 
coded by proto-oncogenes and tumor suppressor genes 
(such as the myc and Bcl proteins or the pRB or p53 and 
others); enzymes required for DNA synthesis and for 
DNA repair[45,46].
Critical evidence that some of  these activities may be 
affected by acetaldehyde produced during ethanol con-
sumption was provided by several authors, who showed 
that chronic ethanol consumption results in inhibition of  
the DNA alkylation repair by O6-methylguanine trans-
ferase (O6-MeGT), which removes alkyl groups from the 
O6-position of  guanine. Acetaldehyde has been shown to 
inhibit O6-MeGT[10,47-49]. Further, exposure to ethanol was 
reported in recent studies to interfere with the cell division 
machinery by perturbing the key G2 cycling protein[50].
Concerning the covalent binding to nuclear lipids, it 
should be noted that all lipid fractions were involved in 
our studies performed in the case of  liver. Part of  the 
covalent binding was acid labile, but a significant part was 
not. The labile portion might be attributable to the pres-
ence of  Schiff  base adducts of  acetaldehyde with amino 
groups from phospholipids[30]. In effect, previous studies 
from other laboratories reported that amino-containing 
phospholipids like phosphatidylserine and phosphatidyl-
ethanolamine formed Schiff  base adducts[51,52].
The fraction of  covalent binding resistant to acid hy-
drolysis might be attributed in part to addition reactions 
of  1-hydroxyethyl on unsaturated fatty acid double bonds 
or on cholesterol moieties and on nitrogen-containing 
phospholipids. That behavior was previously reported 
for the case of  other carbon-centered free radicals, for 
example the trichloromethyl radicals[53,54].
Another part of  the covalent binding to lipids resis-
tant to mild acid media might also be attributed to the 
in replicating cells[35].
It is of  particular interest in this respect that studies 
by Freudenheim et al[36] reported results that were consis-
tent with an increased likelihood of  tumors with p53 mu-
tations for pre-menopausal breast cancer with increased 
alcohol intake 10 or 20 years previous. For intakes of  16 
or more drinks per month in the period of  20 years be-
fore the interview compared with non drinkers, the OR 
was 5.25 (95%, 1.48-18.58)[36].
Acetaldehyde is also known to bind to proteins and 
amino acids and the subject might also be relevant to 
potential carcinogenic effects of  alcohol drinking in dif-
ferent organs.
However, non specific studies related to breast cancer 
and alcohol drinking and the potential participation of  
acetaldehyde protein binding are available at present in 
literature. Notwithstanding, it is well known that acetal-
dehyde binds to reactive lysine residues, to some aromatic 
amino acids, cysteine, or to free alpha-amino groups, such 
as the terminal valine of  hemoglobin. The subject was 
thoroughly reviewed by Niemelä[37], who also pointed the 
relevance of  those interactions in different pathologies 
occurring in several tissues other than the breast.
In this respect, it might be relevant to take in consid-
eration that acetaldehyde was shown to bind covalently to 
liver nuclear proteins[30]. In the case of  liver, the biotrans-
formation of  ethanol to acetaldehyde may occur not only 
in the cytoplasm or in the endoplasmic reticulum but also 
in the nearby outer nuclear membrane[30,38]. Acetaldehyde, 
despite being a reactive molecule, does not have the 
equivalent reactivity to the one of  a low molecular weight 
free radical (for example, trichloromethyl or 1-hydroxy-
ethyl). This allows it to travel from cellular distant sites 
(cytoplasm or endoplasmic reticulum) to the nucleus and 
interact with DNA and nuclear proteins or lipids when 
acetaldehyde accumulates for long periods of  time as 
those observed to occur in mammary tissue after alcohol 
drinking.
In the case of  other liver carcinogenic chemicals, like 
carbon tetrachloride, a good correlation was observed 
between the covalent binding of  its reactive metabolites 
to nuclear proteins and carcinogenicity. The interaction 
involved histone and non-histone proteins. Acidic and 
residual nuclear proteins were the favorite targets of  that 
interaction and showed a good correlation between those 
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Figure 2  Structures of some of acetaldehyde-guanine adducts.
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formation of  ethyl esters of  fatty acids. It is known that 
liver microsomes and cytosol contain enzyme systems 
able to esterify free fatty acids or transesterify other esters 
to ethyl esters[55-57]. Whether nuclear preparations from 
mammary tissue have similar ability remains to be estab-
lished. Irrespectively of  the present lack of  knowledge 
about the structure of  the reaction products formed, it is 
not unexpected to envisage that the alteration of  nuclear 
membranes by their reaction with either acetaldehyde or 
1-hydroxyethyl or resulting from ester formation with 
ethanol, might lead to profound alterations in liver nucle-
ar functions. It is well established that ethanol also strik-
ingly alters other liver membranes and their fluidity[58]. It 
is known that nuclear lipids may be part of  an intracel-
lular signaling system modulating protein kinase C, an en-
zyme involved in phosphorylation of  nuclear proteins[59]. 
The covalent binding to nuclear phospholipids deserves 
special interest since they have a known ability to regulate 
gene function, nucleosome structure, RNA synthesis and 
activation of  DNA polymerase alpha[59-65]. Past studies 
from the laboratory reported correlations between altera-
tions in nuclear lipids resulting from a free radical attack 
and the different response of  the rat strains employed to 
the carcinogenic effects of  CCl4[54].
FREE RADICALS, OXIDATIVE STRESS 
AND EFFECTS
Oxidative stress was also considered to be a potential 
factor involved in the alcohol drinking promoted carci-
nogenic effect on mammary tissue. Notwithstanding this, 
no evidence of  its occurrence in mammary tissue were 
reported until our recent studies where we showed that 
oxidative stress can be observed in this tissue after an ex-
perimental protocol of  28 d of  alcohol drinking through 
the Lieber and De Carli diet[15,22,25]. It is relevant at this 
point to have present what “oxidative stress” is all about. 
Oxidative stress has been defined as an imbalance be-
tween oxidants and antioxidants in favor of  the former, 
resulting in an overall increase in cellular levels of  reactive 
oxygen species (ROS). Many pathways play a role in how 
ethanol induces oxidative stress in the liver (the issue has 
exercised the interest of  numerous researches for years) 
and is reviewed in Cederbaum et al[66]. Ethanol-induced 
oxidative stress in the liver included the ability to gener-
ate free radicals able to initiate the process (for example, 
1-hydroxyethyl and hydroxyl radicals) and formation of  
hydroperoxides, peroxides, superoxide, H2O2 and other. 
In the case of  liver exposed to alcohol, the evidence in-
cluded the formation of  products derived from the attack 
of  ROS to relevant target molecules (for example, DNA, 
proteins or lipids) like 8-oxodeoxyguanosine, protein 
carbonyls, decreases in protein sulfhydryls, lipid hydro-
peroxides and other products such as malondialdehyde or 
4-hydroxy-2-nonenal (4HNE)[66].
The evidence that cellular antioxidant defenses were 
overwhelmed might include determinations of  the variety 
of  enzymatic and non-enzymatic mechanisms that have 
evolved to protect cells against ROS such as superoxide 
dismutase, catalase, glutathione peroxidase, GST and 
other enzymes. Also are relevant low molecular weight 
antioxidants, such as glutathione itself, vitamin E, ascor-
bate, vitamin A and others. In summary, toxicity induced 
by ROS reflects the balance between the rates of  produc-
tion of  ROS compared to the rates of  removal of  ROS 
plus repair of  damage to cellular macromolecules[66].
After these introductory remarks learnt from free 
radical cell injury and from the effects of  alcohol on liver, 
let us to introduce what kind of  evidence we obtained for 
the case of  mammary tissue.
Initially we began to consider the possibility that 
during alcohol drinking an oxidative stress process oc-
curred in mammary tissue because in our hands repeti-
tive alcohol drinking exposure led to increased XOR 
and lipoxygenase activities in the rat mammary tissue[22]. 
In effect, increased XOR and lipoxygenase activities by 
themselves would lead to not only higher generation of  
ROS, but also when occurring in the presence of  ethanol, 
to increased generation of  free radicals. The formation 
of  hydroxyl radicals was detected during XOR mediated 
cytosolic alcohol metabolism[16].
Other reason leading to a similar potential effect was 
derived from our observation that acetaldehyde accumu-
lates in mammary tissue during repetitive alcohol drink-
ing[15]. It is well known that the generation of  increased 
level of  acetaldehyde may provoke decreases in GSH as 
it was respectively observed in liver[66]. Further, GSH and 
GSH-dependent enzymes such as glutathione peroxi-
dase, glutathione reductase and glutathione transferase 
are a vital first line defense against oxidative stressful 
conditions[66].
The initial observation indicating that alcohol drink-
ing could provoke oxidative stress that we obtained was 
derived from our studies in the t-butylhydroperoxide-
induced chemiluminescence in mammary tissue homog-
enates from rats exposed to repetitive alcohol drinking 
when compared to those from control animals[15].
The samples from alcohol treated animals had a com-
pletely different response to the t-butylhydroperoxide 
challenge and the shape of  their response curve com-
pared to that observed in the control samples clearly sug-
gested that animals exposed to alcohol have diminished 
defenses against t-butylhydroperoxide challenge[15]. How-
ever, that experiment did not give indication about the 
nature of  the defensive process that was compromised. 
Further, it did not show which target molecule involved 
the potential oxidative process that was occurring.
To answer those questions, other studies were per-
formed and we found that after repetitive alcohol drink-
ing, the levels of  lipid hydroperoxides in mammary 
tissue were significantly increased. Further, the protein 
sufhydryl and vitamin E content in the alcohol-treated 
animals decreased. However, in those experiments we did 
not observe protein carbonyl enhancement or increased 
formation of  8-hydroxyguanine[22]. One reason to explain 
that different response to alcohol drinking-provoked 
oxidative stress might be that much longer periods of  
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expose to alcohol could be necessary. That is in our work 
we were detecting early manifestations of  alcohol drink-
ing induced oxidative stress in mammary tissue.
If  that was the case, after more prolonged periods of  
alcohol drinking, other relevant effects might occur de-
rived from generation of  harmful reactive aldehydes pro-
duced from lipid peroxidation such as malondialdehyde 
and 4HNE. They are able to react with proteins, lipids 
and with sufhydryl-containing molecules of  low molecu-
lar weight[33,66]. See Figure 3 for their structures.
The reaction with sufhydryl groups that we observed 
might be of  significance considering that many sufhydryl-
containing enzymes play a key role in cell functioning and 
also in cell signaling processes[67-70].
Free radicals not only are relevant in relation to the 
carcinogenesis initiation step. The progress of  human 
breast cancer to the metastasis stage was linked to hy-
droxyl radical-induced DNA damage[71].
These findings should be of  some significance in 
light of  the well established correlation between oxidative 
stress and tumor promotion and cancer[72-74].
INCREASED LEVELS OF ESTROGENS 
AND CONSEQUENCES
Increased plasmatic levels of  estrogen by alcohol drink-
ing have been clearly demonstrated in controlled feed-
ing studies in human female volunteers[75-84]. Further, 
the hypothesis about the role of  estrogens in alcohol 
drinking-induced breast cancer is strongly supported by 
the fact that their higher risk was related to estrogen re-
ceptor ER-positive rather than to ER-negative mammary 
tumors[85-88]. However, estrogens may exert their carci-
nogenic effects in mammary tissue not only via ER, but 
also by direct damage to DNA[89]. Metabolic activation of  
estrogens to catechol-3,4-quinones is an example. These 
reactive metabolites are able to interact with DNA to give 
mutational events[90-93]. Those increased levels of  estro-
gen after alcohol drinking would arise because alcohol 
increases aromatase activity and that leads to enhanced 
conversion of  testosterone to estrogen, resulting in de-
creased testosterone and increased estrogen level[94].
These considerations might be of  particular relevance, 
since there are available in literature clear evidences that 
high levels of  estrogen in blood are associated with an 
increased risk of  breast cancer[94]. 
One major mechanism of  action of  estrogens is that 
by which estrogen stimulates cell proliferation through 
nuclear ER-mediated signaling pathways, thus resulting 
in an increased risk of  genomic mutations during DNA 
replications[95-97].
Another pathway involves estrogen metabolism that 
is mediated by cytochrome P450 1B1, which generates 
2- and 4-catechol estrogens that easily autoxidize to the 
respective quinones, even without the need for enzymatic 
or metal ion catalysis[98]. At this point it is particularly 
relevant to do mention that alcohol consumption was 
reported to significantly increase the rate of  NADPH-de-
pendent oxidative metabolism of  estrogens to quinones 
in females. CYP1B1 had a distinct, selective activity for 
the 4-hydroxylation of  estradiol and estrone[99]. This in-
ductive effect of  alcohol drinking might increase chances 
of  participation of  cytochrome-mediated pathway in 
relation to other related to direct interactions of  the es-
trogens with ER.
It is our idea that, under conditions where oxidative 
stress or peroxidizing conditions occur (like those report-
ed by our laboratory to occur during exposure of  mam-
mary tissue to alcohol), the transformation of  one to the 
other might be even further facilitated.
In addition, o-quinones are also potent redox-active 
compounds[98,100]. For example, these quinones can be 
reductively detoxified by a quinone reductase in a two-
electron transfer process[101]. However, they can also un-
dergo redox cycling with the semiquinone form of  P450 
reductase (a one-electron process) and generate superox-
ide radicals, that in the presence of  iron or other transi-
tion metal give hydroxyl radicals[100] (Figure 4).
By the other hand, the estrogen quinones can di-
rectly damage DNA leading to genotoxic effects[102,103]. 
DNA adducts of  estrogen quinones have been detected 
in the mammary glands of  ACI rats treated with 4-hy-
droxyestradiol or its quinones[103]. Further, recently devel-
oped highly sensitive LC/MS-MS procedures were used 
to analyze DNA from human breast tumors and their 
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O
adjacent tissue and the DNA adducts formed from estro-
gen quinones were detected[104].
All these results suggest that these mechanisms might 
be relevant for the carcinogenic effects of  estrogens by 
themselves. However, there is not available in literature 
evidence of  their formation in mammary tissue from al-
cohol drinking animals or humans at present.
As part of  our present working hypothesis about 
the contribution of  estrogens in the alcohol drinking ef-
fects in mammary tissue, we assumed that these estrogen 
quinones might be formed (Figure 4). The reasons for 
that hypothesis are going to be described ahead and are 
related to some of  our results. 
It is relevant to understand our “views” about the co-
operative effects between alcohol metabolism to acetal-
dehyde, its ability to promote oxidative stress and the par-
ticipation of  induced levels of  estrogen in carcinogenic 
effects in mammary tissue to describe what happens with 
the catechol estrogens and the estrogen quinones after 
their formation.
The catechol estrogens may be further metabolized 
by O-methylation, by reaction with glutathione, and also 
by glucuronidation and sufation[105,106].
Interestingly, catechol estrogen metabolites display 
a less intense ER-mediated estrogenic activity, implying 
that catechol estrogens are attributed to have both, direct 
genotoxic effects as well as ER-mediated tumor promoter 
actions[107]. Further, sulfate and glucuronide conjugates 
seem to play a role for free estrogens and, in general, it is 
at present a controversy about conjugation metabolism, 
if  they may mitigate the catechol estrogen-mediated car-
cinogenic properties[107].
Notwithstanding, being the conjugated estrogens 
more water-soluble they seemed to be more readily ex-
creted than the lipophilic parent estrogens[107]. These 
suggest that the conjugation pathway is considered as a 
protection mechanism against damage caused by reactive 
metabolites of  estrogens[105].
An important aspect of  the mechanism of  generation 
of  estrogen quinones from catechol estrogens concerns 
the resulting formation of  ROS during the process. In ef-
fect, ROS are generated via the redox cycling between cat-
echol estrogens and their quinone analogs[108-110] (Figure 4).
Catechol estrogens can be oxidized by any oxidative 
enzyme or metal ions such as Cu2+ or Fe3+ to give rise to 
semiquinones and o-quinones[108-110]. Is our hypothesis 
that it might very well be that this activating pathway 
of  the catechol estrogens was stimulated during alcohol 
drinking by the inductive effect of  alcohol on mammary 
tissue XOR and lipoxygenase or even more likely, by the 
alcohol drinking promoted oxidative stress that was ob-
served[15,22,25].
The reduction of  o-quinones back to semiquinones 
and catechols by P450 reductase provides an opportu-
nity to generate ROS, including superoxide and hydroxyl 
radicals[107].
In our experiments on the effect of  alcohol drinking 
on rat mammary tissue we were able to detect the forma-
tion of  hydroxyl radicals and lipid hydroperoxides during 
the metabolism of  ethanol in this tissue[16,22].
In those studies we also reported that repetitive alco-
hol drinking provoked the depletion of  defenses against 
oxidative stress insult due to significantly reduced levels 
of  glutathione, α-tocopherol and defensive enzymes such 
as glutathione transferase and glutathione reductase[25]. 
Besides the consequences that those effects have on the 
oxidative stress process itself  and in the promotion of  
the carcinogenic process[73], this might have additional 
relevant consequences for the contribution of  estrogens 
to the mammary carcinogenic process. In effect, glutathi-
one is also able to react with the estrogen quinones and 
semiquinones to give glutathione conjugates in a reaction 
catalyzed by glutathione transferase[107]. Further, the low-
ered levels of  glutathione would also decrease the capac-
ity of  mammary tissue to destroy hydroperoxides since 
it is the necessary cofactor for glutathione peroxidase to 
operate even when the levels of  this enzyme were not 
decreased[25]. 
Decreased levels of  two critical antioxidants like vita-
min E and glutathione that we observed in mammary tis-
sue after alcohol drinking might be not only of  relevance 
for the promotion of  oxidative stress[25], but also to un-
derstand that their depletion might be a potential factor 
of  the genotoxic effect of  estrogens, via their oxidative 
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metabolism that might be enhanced[107] (Figure 4).
The increased generation of  ROS produced by alco-
hol toxicity[66] and the effects of  estrogen[107] might ex-
plain the decreased levels of  α-tocopherol observed[25].
In addition, the significantly decreased levels of  GST 
observed in our experiments on the effect of  alcohol 
drinking on mammary tissue might also be explained as 
attributable to the potent inhibitory effects that specific 
glutathione-estrogen metabolites have on the GST mol-
ecule[111-113]; of  course that remain to be proved. It might 
of  particular relevance in light of  previous observations 
reported by Zheng et al[114] in epidemiological studies, that 
alcohol consumption increased breast cancer risk in wom-
en among those who carry susceptible GST genotypes.
Not only the GSH/GST detoxicating pathway of  
the estrogen metabolites could be negatively modulated 
by alcohol drinking. Other might be the carboxymethyl 
transferase (COMT) pathway of  catechol estrogens meth-
ylation (Figure 5). Several points of  the cycle depicted 
in that process are already known that might be altered 
during alcohol drinking. For example, the S-adenosylme-
thionine (SAM) involved in the methyltransferase step 
of  catechol estrogens methylation is known to be dimin-
ished because of  SAM decreased hepatic biosynthesis. 
In alcoholic liver disease methionine adenosyltransferase 
capacity is affected. In fact, chronic alcoholics have hy-
permethioninemia and impaired methionine clearance[115]. 
That leads to decreased SAM biosynthesis and in turn to 
impact on methylation capacity of  the cell and decreased 
antioxidant defenses[115].
Further, chronic exposure to ethanol has been shown 
not only to decrease hepatic SAM levels, but also to in-
crease hepatic concentrations of  S-adenosylhomocysteine 
and decrease plasma concentrations of  folate in animals 
and humans[115,116]. In turn, homocysteine may exert patho-
genic effects largely through metabolic accumulation 
of  SAH, which is a strong non-competitive inhibitor of  
COMT-mediated methylation metabolisms of  various cat-
echol substrates, including those arising from estrogens[117].
In addition to depleting folate concentrations, chronic 
ethanol exposure decreases the activity of  methionine 
synthase, which is required to catalyze the transfer of  a 
methyl group from folate to homocysteine to form me-
thionine[116,118,119].
All these facts might decrease the ability of  COMT 
to methylate harmful catechol estrogens during chronic 
alcohol drinking as we describe in our working hypoth-
esis about the concerted action of  alcohol drinking, the 
formation of  deleterious acetaldehyde, free radicals, oxi-
dative stress and increased levels of  estrogens.
WORKING HYPOTHESIS ABOUT HOW 
ALCOHOL DRINKING MIGHT PROMOTE 
CARCINOGENIC EFFECTS IN MAMMARY 
TISSUE
Considering the growing evidence about the relevance 
of  acetaldehyde participation in the alcohol drinking-
carcinogenic effects in target organs (for example, the 
aerodigestive tract) we consider that its in situ formation 
and accumulation in mammary tissue should play a role. 
Contribution of  acetaldehyde arriving via blood supply 
should play some but a minor role.
Taking into account that oxidative stress promotion 
was observed and that free radical generation systems are 
present in mammary tissue exposed to ethanol during 
alcohol drinking we felt that it was relevant to consider 
oxidative stress as a relevant participant in the alcohol 
drinking promoted carcinogenic effects on mammary tis-
sue. It is well known that it plays a role in promotion and 
initiation of  tumors induced by other chemicals acting in 
other tissues as well as in mammary tissue.
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Finally, alcohol drinking is also known to increase 
estrogen blood levels in animals and human beings and it 
is an established carcinogen for mammary tissue[95,120]. In 
women, Eriksson et al[121] observed an estrogen associated 
acetaldehyde elevation after alcohol intake.
Alcohol is able also to provoke even on culture studies 
proliferative and cell transforming effects, not only via es-
trogen receptors but also as a “chemical carcinogen”, me-
diated by products of  their oxidative metabolism[87,122,123].
In light of  the remarkable susceptibility of  mammary 
tissue to alcohol drinking, clearly evidenced in epidemio-
logical studies, we coined the working hypothesis that 
the resulting deleterious carcinogenic effects might arise 
from a sort of  collaborative participation of  these three 
components, making some of  them more susceptible to 
the effect of  the other. Some of  those possibilities are 
going to be described at the time of  proposing potential 
preventive treatments that we postulate based on existing 
linked literature.
Only the challenge of  the hypothesis will tell whether 
is valid or not. Lack of  hypothesis does lead to new ex-
periments. New experiments may show the need of  a new 
one. The present one in our hands is shown in Figure 6.
POTENTIAL PREVENTIVE TREATMENTS 
AGAINST ALCOHOL DRINKING 
DELETERIOUS EFFECTS IN MAMMARY 
TISSUE
The first point to mention is that being alcohol drink-
ing one of  the few causes of  breast cancer promotion a 
wise suggestion might be not to drink. Notwithstanding 
we feel that epidemiology shows that the real success 
of  that advice may not be easily achievable. The present 
suggested tolerance for alcohol drinking by women is of  
one daily drink[4]. The analysis of  the potential preventive 
strategies for women deciding to moderately exceed that 
suggested tolerated levels will be analyzed in light of  the 
existing knowledge and of  our working hypothesis.
The preventive alternatives to be analyzed include: 
(1) Blockade of  acetaldehyde generation and accumula-
tion in mammary tissue; (2) Prevention of  alcohol and 
estrogen-induced oxidative stress in mammary tissue by 
antioxidants; (3) Treatments increasing defenses against 
estrogen provoked effects; and (4) Treatments able to be 
preventive in different aspects of  the problem.
Inhibitory effects on acetaldehyde generating enzymes 
present in mammary tissue
Considering that most of  the acetaldehyde accumulating 
in mammary tissue was generated in situ[15], we considered 
of  particular interest to pay attention to inhibitors of  the 
two pathways already evidenced by our laboratory, one 
present in cytosolic fraction and mediated by XOR and 
other, located at the microsomal fraction being linked to 
a lipoxygenase activity[8,16,17,124-126].
It was of  our especial interest the search for com-
pounds present in food or drinks or available as dietary 
supplements, having low toxicity, potent inhibitory effects 
and ideally acting on both, the cytosolic plus microsomal 
pathways of  ethanol metabolism to acetaldehyde[127,128].
Several phytochemicals of  polyphenolic nature tested 
appeared as potential candidates exhibiting those interest-
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ing characteristics and deserve our future attention. The 
most potent inhibitors among those polyphenols were 
flavonols quercetin, myricetin and kaempferol; also the 
flavones apigenin, luteolin and the polyphenols nordihy-
droguaiaretic acid and ellagic acid. Their structures are 
shown in Figure 7.
It might be important to consider at this point that 
several polyphenols were found to be inhibitory of  carci-
nogenesis in laboratory investigations[129-131].
The case of  ellagic acid particularly attracted our 
interest because it is present in several fruit sources[132]. 
This compound was able to diminish estrogen-mediated 
mammary tumorigenesis in ACI rats[133]. Other authors 
reported anti-proliferative activities in vitro with several 
cell types[134]. And more, it also exhibited beneficial anti-
cancer effects based in a chemical study in male prostate 
cancer patients[135,136].
We also found that folic acid behaved a highly po-
tent inhibitor of  acetaldehyde formation in the cytosolic 
fraction of  mammary tissue[124]. That suggests a preven-
tive effect mediated not only by acetaldehyde depletion 
but also because it is a critical component of  the overall 
methylation processes. Folate was found to be relevant in 
the prevention of  breast cancer[137].
Removal of acetaldehyde accumulated in mammary 
tissue
Past studies from our laboratory evidenced that acetalde-
hyde accumulates in mammary tissue during long periods 
of  time, even after single doses of  ethanol given orally[15]. 
Removal of  acetaldehyde from mammary tissue ap-
pears far more difficult than in liver. In effect, the ALDH 
activity in mammary tissue subcellular fractions (cytosol, 
mitochondria and microsomes) was at least ten times 
lower than in the liver[15]. In addition, the relevant mi-
tochondrial ALDH activity might become irreversibly 
inhibited by the lipid peroxidation byproduct 4HNE, 
which is a potent inhibitor as well as a substrate for 
ALDH[138,139]. Lipid peroxidation might occur during the 
oxidative stress produced by ethanol acting on mammary 
tissue[22]. Further, the other potential GSH/GST system 
able to get rid of  acetaldehyde is significantly decreased 
in mammary tissue after repetitive alcohol drinking[25].
Other alternative to eliminate acetaldehyde accumula-
tion in mammary tissue might arise from cysteine admin-
istration. Cysteine is able to ameliorate the toxicity of  
acetaldehyde by forming a stable adduct, the 2-methylthi-
azolidine-4-carboxylic acid[140] (Figure 8). Its efficiency to 
lower the acetaldehyde accumulation in mammary tissue 
remains to be established. This alternative was suitably 
employed to prevent acetaldehyde accumulation in the 
oral cavity during alcohol drinking[141,142].
In the case of  mammary tissue, we consider N-acet-
ylcysteine (NAC) as having more likely potential preven-
tive action. NAC might be less effective than cysteine in 
extracellular environment (e.g., saliva), but can be given at 
higher doses and during longer periods of  time than cys-
teine because of  its lower toxicity and because it is also 
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a precursor of  cysteine and glutathione[143]. In a number 
of  studies since 1984, NAC also proved to have the 
potential to prevent cancer and other mutation-related 
diseases[143].
Prevention of estrogen oxidation or enhancement of 
detoxication of estrogen reactive metabolites
The invoking hypothesis displayed in Figure 6 assumes 
that a significant component in the alcohol drinking 
promotion of  mammary cancer involves de formation 
of  catechol estrogens that might be oxidized to their qui-
nones, which can react with DNA.
The contribution of  alcohol drinking to this deleteri-
ous pathway might involve the inductive effect on CY-
P1B1 and provision of  relevant oxidizing conditions for 
the generation of  the estrogen reactive metabolites and 
the decreased detoxication of  those reactive moieties.
The contribution of  antioxidants if  that hypothesis 
was likely appears attractive to prevent this factor of  the 
alcohol-drinking via the oxidative estrogen metabolism 
component. Recent studies[144] evidenced that the anti-
oxidant N-acetylcysteine, a precursor of  cysteine and of  
intracellular GSH[145] is able to block the initial step in the 
genotoxicity caused by estrogen quinones.
The authors concluded that N-acetylcysteine preven-
tive action included multiple protective mechanisms, 
including nucleophilicity, antioxidant activity and inhibi-
tion of  DNA adduct formation[146]. Preventive properties 
were also observed in human breast epithelial cells and 
mouse mammary epithelial cells[147].
Further, GSH, an ubiquitous antioxidant is able to 
react non-enzymatically with the catechol estrogen qui-
nones or more efficiently, with the catalytic activation of  
GST[101,148].
Resveratrol, a natural antioxidant present in grapes 
and different plant products[149,150] was also effective in in-
hibiting the formation of  estrogen-DNA adducts[146] and 
is also known to exert diverse anticarcinogenic effects in 
vitro and in vivo[149,151].
Dihydrolipoic acid, which is formed in vivo when li-
poic acid is administered, can also inhibit the formation 
of  depurinating estrogen-DNA adducts[146]. Resveratrol 
achieved the highest level of  inhibitory effect and NAC 
or dihydrolipoic acid a moderate action[146].
Interestingly, our laboratory reported that alcohol-
drinking decreased levels of  GSH and α-tocopherol, and 
GST in mammary tissue and enhanced oxidative stress in 
mammary tissue[25].
These alcohol drinking-induced deleterious effects 
should decrease the detoxicating pathway of  glutathione 
conjugates formation and give to the estrogen 3,4-qui-
nones more opportunity to react with DNA to produce 
depurinating adducts.
Other harmful effect of  alcohol drinking may also 
occur at the level of  the COMT detoxicating pathway 
operating at the level of  the catechol estrogens, especially 
the 4-hydroxylated metabolite of  17β-estradiol. In effect, 
the COMT pathway to proceed requires the participation 
of  SAM, folic acid, vitamins B6 and B12 (Figure 5).
The SAM requiring methyl transferase then methyl-
ates the 4-OH group of  the catechol estrogens to give the 
4-OCH3 derivative having less toxic effects[98,107]. In the 
SAM-mediated transmethylation process, S-adenosylho-
mocysteine (SAH) is generated as a product and is hydro-
lyzed afterwards by SAH hydrolase to form homocyste-
ine and adenosine. SAH is a potent competitive inhibitor 
of  the methylation reaction and it is important to remove 
adenosine and homocysteine to prevent accumulation of  
SAH. Re-methylation of  homocysteine requires folic acid 
and vitamin B12. Homocysteine can also form cysteine 
via enzymatic processes requiring vitamin B6. Cysteine is, 
in turn, the rate determining precursor for GSH synthesis 
via a two step enzymatic process. All these processes are 
better reviewed by several authors[115,116,119,152]. See Figure 
5 for a summary of  the SAM-mediated methylation pro-
cess of  catechol estrogens. 
The reason for briefly introducing this matter is that 
this COMT detoxicating process also offers possibilities 
of  preventive treatments.
First it is important to summarize which are the ef-
fects of  alcohol drinking on the components of  the above 
described participating molecules of  the transmethylation 
process.
For example, it has been shown that chronic ethanol 
exposure decrease hepatic concentration of  SAM, in-
creasing plasma concentration of  homocysteine, increase 
hepatic concentration of  SAH and decrease plasma con-
centration of  folate, in animal and human studies[116].
Conversely, exogenous administration of  SAM has 
been shown to attenuate deleterious effects of  alcohol 
drinking in animals. SAM administration is known to re-
store hepatic concentrations of  GSH depleted by alcohol 
drinking[116].
That is, SAM treatment might also be of  help to pre-
vent alcohol drinking effects on mammary induced can-
cer by improving the COMT pathway of  detoxication.
CONCLUSION
Our reviewed considerations about the pathogenesis 
of  alcohol-drinking induced mammary cancer led to 
the working hypothesis that: acetaldehyde accumulation 
and its harmful effects, induced generation of  ROS and 
oxidative deleterious effects on increased estrogen levels 
might cooperatively be involved in cancer promotion. 
That remains to be proved.
If  assumptions were even partially correct, some 
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useful preventive alternatives might be available: inhibi-
tion of  acetaldehyde forming metabolic pathways, de-
struction of  accumulated acetaldehyde, treatments with 
powerful and safe antioxidants and also enhancement of  
estrogen quinones detoxicating pathways. Further, cock-
tails having mixtures of  components from each type 
might be envisaged.
Notwithstanding, it is always important to consider 
that alcohol drinking induced mammary cancer is one of  
the very few avoidable causes of  cancer and it might be 
possible to avoid alcohol drinking at all or more probably 
acceptable to drink just one drink per day (12 g of  etha-
nol per day only).
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